查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1451854

2024-2032 年单核苷酸多态性基因分型市场报告（按技术、应用和地区）

Single Nucleotide Polymorphism Genotyping Market Report by Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2023年全球单核苷酸多态性（SNP）基因分型市场规模达98亿美元。展望未来， IMARC Group预计到2032年市场规模将达到379亿美元，2024-2032年复合年增长率（CAGR）为15.79% 。不断增长的基因型研究和开发活动、对个人化医疗和新型药物输送系统的需求不断增长，以及对动植物原料遗传分析的需求不断增长，是推动市场的一些关键因素。

单核苷酸多态性 (SNP) 基因分型是一种透过检查脱​​氧核糖核酸 (DNA) 序列中的特定位置来识别和分析个体遗传变异的技术。它涉及确定个体 DNA 中特定 SNP 位点上存在的特定核苷酸。它依赖先进的分子生物学技术，例如聚合酶炼式反应（PCR）和DNA测序，其中PCR扩增含有SNP的DNA片段，然后通过直接对扩增的DNA进行测序或使用其他方法来确定SNP位点的核苷酸。微阵列或等位基因特异性 PCR 等方法。它有助于了解群体遗传学、迁移模式和演化历史。它在确定药物反应、预测疾病易感性以及根据特定基因谱定制治疗方面发挥着至关重要的作用。研究人员使用 SNP 基因分型来研究复杂疾病的遗传基础、识别遗传风险因子并开发增强的诊断工具。

单核苷酸多态性 (SNP) 基因分型市场趋势：

目前，由于基因型研究和开发活动的增加以及生物资讯学在开发各种疾病的诊断工具或有效疗法中的应用，对SNP基因分型的需求不断增加，这是支持市场成长的关键因素之一。此外，SNP 基因分型在癌症、心血管、阿兹海默症和气喘等各种人类疾病的病因中的应用日益广泛，提供了良好的市场前景。除此之外，世界各地对 SNP 基因分型建立遗传关係、解决亲子纠纷和协助刑事调查的需求不断增加。这与蓬勃发展的医疗产业一起推动了市场的成长。此外，由于个人化医疗和新型药物输送系统的管道不断增加，对药物基因组学的需求不断增加，正在加强市场的成长。除此之外，生命科学领域的许多SNP基因分型技术，如农业生物技术、诊断研究、製药、药物基因组学以及动物和牲畜育种，正在促进市场的成长。与此一致的是，全球糖尿病、心血管疾病和癌症盛行率的不断上升正在对市场产生积极影响。此外，对动植物原料遗传分析的需求不断增长，也推动了市场的成长。

本报告回答的关键问题：

  • 迄今为止，全球单核苷酸多态性 (SNP) 基因分型市场的表现如何，未来几年将如何表现？
  • 全球单核苷酸多态性 (SNP) 基因分型市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球单核苷酸多态性 (SNP) 基因分型市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的单核苷酸多态性 (SNP) 基因分型市场？
  • 基于技术的市场区隔是什么？
  • 单核苷酸多态性 (SNP) 基因分型市场中最具吸引力的技术是什么？
  • 基于应用程式的市场区隔是什么？
  • 单核苷酸多态性 (SNP) 基因分型市场中最具吸引力的应用是什么？
  • 全球单核苷酸多态性（SNP）基因分型市场的竞争格局如何？
  • 全球单核苷酸多态性 (SNP) 基因分型市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球单核苷酸多态性 (SNP) 基因分型市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依技术

  • TaqMan SNP 基因分型
    • 市场走向
    • 市场预测
  • Massarray SNP 基因分型
    • 市场走向
    • 市场预测
  • SNP 基因晶片阵列
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 动物遗传学
    • 市场走向
    • 市场预测
  • 工厂改进
    • 市场走向
    • 市场预测
  • 诊断研究
    • 市场走向
    • 市场预测
  • 药物和药物基因组学
    • 市场走向
    • 市场预测
  • 农业生物技术
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 9 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Eurofins Genomics (Eurofins Scientific SE)
    • Illumina Inc.
    • Integrated DNA Technologies, Inc. (Danaher Corporation)
    • LGC Limited
    • PREMIER Biosoft
    • Promega Corporation
    • QIAGEN NV
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A8146

The global single nucleotide polymorphism (SNP) genotyping market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.9 Billion by 2032, exhibiting a growth rate (CAGR) of 15.79% during 2024-2032. The growing genotype research and development activities, rising demand for personalized medicine and novel drug delivery systems, and increasing demand for genetic analysis in animal and plant feedstock represent some of the key factors driving the market.

Single nucleotide polymorphism (SNP) genotyping is a technique designed to identify and analyze genetic variations among individuals by examining specific locations within their deoxyribonucleic acid (DNA) sequence. It involves determining the specific nucleotide present at a particular SNP site in the DNA of an individual. It relies on advanced molecular biology techniques, such as polymerase chain reaction (PCR) and DNA sequencing, wherein PCR amplifies the DNA segment containing the SNP, and then the nucleotide at the SNP site is determined either by directly sequencing the amplified DNA or using other methods like microarrays or allele-specific PCR. It aids in understanding population genetics, migration patterns, and evolutionary history. It plays a crucial role in determining response to medications, predicting disease susceptibility, and tailoring treatments to specific genetic profiles. SNP genotyping is used by researchers to study the genetic basis of complex diseases, identify genetic risk factors, and develop enhanced diagnostic tools.

Single Nucleotide Polymorphism (SNP) Genotyping Market Trends:

At present, the increasing demand for SNP genotyping on account of the rising genotype research and development activities and bioinformatics in the development of diagnostic tools or effective therapeutics for various diseases represents one of the crucial factors supporting the growth of the market. In addition, the growing utilization of SNP genotyping in the etiology of various human diseases, such as cancer, cardiovascular, Alzheimer's, and asthma, is offering a favorable market outlook. Besides this, there is a rise in the demand for SNP genotyping to establish genetic relationships, resolve paternity disputes, and assist in criminal investigations around the world. This, along with the thriving medical industry, is propelling the growth of the market. Moreover, the increasing demand for pharmacogenomics due to the rising pipeline for personalized medicine and novel drug delivery systems is strengthening the growth of the market. Apart from this, numerous technologies of SNP genotyping in the life science field, such as agricultural biotechnology, diagnostic research, pharmaceuticals, pharmacogenomics, and animal and livestock breeding, are contributing to the growth of the market. In line with this, the growing prevalence of diabetes, cardiovascular diseases, and cancer across the globe is positively influencing the market. Furthermore, the rising demand for genetic analysis in animal and plant feedstock is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global single nucleotide polymorphism (SNP) genotyping market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology and application.

Technology Insights:

TaqMan SNP Genotyping

Massarray SNP Genotyping

SNP GeneChip Arrays

Others

The report has provided a detailed breakup and analysis of the single nucleotide polymorphism (SNP) genotyping market based on the technology. This includes TaqMan SNP genotyping, massarray SNP genotyping, SNP GeneChip arrays, and others.

Application Insights:

Animal Genetics

Plant Improvement

Diagnostic Research

Pharmaceuticals and Pharmacogenomics

Agricultural Biotechnology

Others

A detailed breakup and analysis of the single nucleotide polymorphism (SNP) genotyping market based on the application has also been provided in the report. This includes animal genetics, plant improvement, diagnostic research, pharmaceuticals and pharmacogenomics, agricultural biotechnology, and others. According to the report, pharmaceuticals and pharmacogenomics accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for single nucleotide polymorphism (SNP) genotyping. Some of the factors driving the North America single nucleotide polymorphism (SNP) genotyping market included favorable government policies towards proper diagnosis, increasing screening and treatment of fatal diseases, availability of enhanced research and development (R&D) facilities, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global single nucleotide polymorphism (SNP) genotyping market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Eurofins Genomics (Eurofins Scientific SE), Illumina Inc., Integrated DNA Technologies, Inc. (Danaher Corporation), LGC Limited, PREMIER Biosoft, Promega Corporation, QIAGEN N.V, Roche Holding AG, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global single nucleotide polymorphism (SNP) genotyping market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global single nucleotide polymorphism (SNP) genotyping market?
  • What is the impact of each driver, restraint, and opportunity on the global single nucleotide polymorphism (SNP) genotyping market?
  • What are the key regional markets?
  • Which countries represent the most attractive single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the single nucleotide polymorphism (SNP) genotyping market?
  • What is the competitive structure of the global single nucleotide polymorphism (SNP) genotyping market?
  • Who are the key players/companies in the global single nucleotide polymorphism (SNP) genotyping market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Single Nucleotide Polymorphism (SNP) Genotyping Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 TaqMan SNP Genotyping
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Massarray SNP Genotyping
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 SNP GeneChip Arrays
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Animal Genetics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Plant Improvement
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diagnostic Research
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceuticals and Pharmacogenomics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Agricultural Biotechnology
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Eurofins Genomics (Eurofins Scientific SE)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Illumina Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Integrated DNA Technologies, Inc. (Danaher Corporation)
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 LGC Limited
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 PREMIER Biosoft
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Promega Corporation
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 QIAGEN N.V
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Roche Holding AG
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Thermo Fisher Scientific Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Major Drivers and Challenges
  • Figure 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Single Nucleotide Polymorphism (SNP) Genotyping (TaqMan SNP Genotyping) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Massarray SNP Genotyping) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Single Nucleotide Polymorphism (SNP) Genotyping (SNP GeneChip Arrays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Animal Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Plant Improvement) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Diagnostic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Pharmaceuticals and Pharmacogenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Agricultural Biotechnology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Single Nucleotide Polymorphism (SNP) Genotyping (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: North America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: United States: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Canada: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Asia-Pacific: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: China: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: China: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Japan: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: India: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: India: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: South Korea: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Australia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Indonesia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Europe: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Germany: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: France: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: France: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: United Kingdom: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Italy: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Spain: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Russia: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Latin America: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Brazil: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Mexico: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market: Breakup by Country (in %), 2023
  • Figure 75: Middle East and Africa: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Drivers, Restraints, and Opportunities
  • Figure 77: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Value Chain Analysis
  • Figure 78: Global: Single Nucleotide Polymorphism (SNP) Genotyping Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Competitive Structure
  • Table 6: Global: Single Nucleotide Polymorphism (SNP) Genotyping Market: Key Players